{"id":1133123,"date":"2024-02-04T17:25:32","date_gmt":"2024-02-04T19:25:32","guid":{"rendered":"https:\/\/teknomers.com\/fr\/action-novo-nordisk-ce-que-les-analystes-attendent-de-novo-nordisk\/"},"modified":"2024-02-04T17:25:39","modified_gmt":"2024-02-04T19:25:39","slug":"action-novo-nordisk-ce-que-les-analystes-attendent-de-novo-nordisk","status":"publish","type":"post","link":"https:\/\/teknomers.com\/fr\/action-novo-nordisk-ce-que-les-analystes-attendent-de-novo-nordisk\/","title":{"rendered":"Action Novo Nordisk : ce que les analystes attendent de Novo Nordisk"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<p>Le mois dernier, certains analystes ont revu leurs notes sur les actions de Novo Nordisk.<\/p>\n<div>\n<p>13 analystes ont r\u00e9v\u00e9l\u00e9 leur \u00e9valuation des actions Novo Nordisk.<\/p>\n<p>8 experts classent l&#8217;action Novo Nordisk comme un achat, 3 experts recommandent de conserver l&#8217;action, 2 experts \u00e9valuent l&#8217;action comme une vente.<!-- sh_cad_2 --><\/p>\n<p>En moyenne, les analystes pr\u00e9voient un objectif de cours de 749,23 DKK pour Novo Nordisk.  Cela signifie une augmentation de CHF 699,56 par rapport au prix actuel de la SWX de CHF 49,67.<\/p>\n<p>La tendance de la notation sur 6 mois est \u00e0 l&#8217;achat.<\/p>\n<table class=\"table table--content-right table--col-2-text-align-center\">\n<thead class=\"table__thead\">\n<tr class=\"table__tr\">\n<th class=\"table__th\">Analyste<\/th>\n<th class=\"table__th\"\/>\n<th class=\"table__th\">Objectif de prix<\/th>\n<th class=\"table__th\">Objectif de prix \u00e0 distance<\/th>\n<th class=\"table__th\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"table__tbody\">\n<tr class=\"table__tr\">\n<td class=\"table__td\">JP Morgan Chase &#038; Co.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--positive arrow--analysis\"\/><\/td>\n<td class=\"table__td\">850,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 611,29<\/td>\n<td class=\"table__td\">31 janvier 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">UBS SA<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--analysis\"\/><\/td>\n<td class=\"table__td\">795,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 500,56<\/td>\n<td class=\"table__td\">31 janvier 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">Jefferies &#038; Compagnie Inc.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--negative arrow--analysis\"\/><\/td>\n<td class=\"table__td\">465,00 DKK<\/td>\n<td class=\"table__td font-color-green\">836.18<\/td>\n<td class=\"table__td\">31 janvier 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">UBS SA<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--analysis\"\/><\/td>\n<td class=\"table__td\">795,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 500,56<\/td>\n<td class=\"table__td\">30 janvier 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">JP Morgan Chase &#038; Co.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--positive arrow--analysis\"\/><\/td>\n<td class=\"table__td\">850,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 611,29<\/td>\n<td class=\"table__td\">24\/01\/2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">Barclays Capital<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--positive arrow--analysis\"\/><\/td>\n<td class=\"table__td\">825,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 560,96<\/td>\n<td class=\"table__td\">17 janvier 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">Jefferies &#038; Compagnie Inc.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--positive arrow--analysis\"\/><\/td>\n<td class=\"table__td\">500,00 DKK<\/td>\n<td class=\"table__td font-color-green\">906.64<\/td>\n<td class=\"table__td\">16 janvier 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">UBS SA<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--analysis\"\/><\/td>\n<td class=\"table__td\">795,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 500,56<\/td>\n<td class=\"table__td\">15 janvier 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">JP Morgan Chase &#038; Co.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--positive arrow--analysis\"\/><\/td>\n<td class=\"table__td\">850,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 611,29<\/td>\n<td class=\"table__td\">01\/12\/2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">Deutsche Bank AG<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--positive arrow--analysis\"\/><\/td>\n<td class=\"table__td\">850,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 611,29<\/td>\n<td class=\"table__td\">01\/10\/2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">JP Morgan Chase &#038; Co.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--positive arrow--analysis\"\/><\/td>\n<td class=\"table__td\">850,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 611,29<\/td>\n<td class=\"table__td\">8 janvier 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">Jefferies &#038; Compagnie Inc.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--negative arrow--analysis\"\/><\/td>\n<td class=\"table__td\">465,00 DKK<\/td>\n<td class=\"table__td font-color-green\">836.18<\/td>\n<td class=\"table__td\">01\/03\/2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">JP Morgan Chase &#038; Co.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--positive arrow--analysis\"\/><\/td>\n<td class=\"table__td\">850,00 DKK<\/td>\n<td class=\"table__td font-color-green\">1 611,29<\/td>\n<td class=\"table__td\">02\/01\/2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Equipe \u00e9ditoriale finanzen.net<\/p>\n<\/div>\n<div id=\"\">\n<h2 class=\"headline headline--h4\">Produits \u00e0 effet de levier s\u00e9lectionn\u00e9s sur Novo Nordisk<\/h2>\n<p>Avec les knock-outs, les investisseurs sp\u00e9culatifs peuvent participer de mani\u00e8re disproportionn\u00e9e aux mouvements de prix.  S\u00e9lectionnez simplement le levier que vous souhaitez et nous vous montrerons les produits ouverts appropri\u00e9s sur Novo Nordisk<\/p>\n<p class=\"font-color-red display-none\" id=\"lvgCustomHandleInfo\">L&#8217;effet de levier doit \u00eatre compris entre 2 et 20<\/p>\n<p><span class=\"ad-hint ad-hint--right display-block\">Publicit\u00e9<\/span><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.finanzen.net\/nachricht\/aktien\/experteneinschaetzungen-novo-nordisk-aktie-was-analysten-von-novo-nordisk-erwarten-13219445\" rel=\"nofollow noopener\" target=\"_blank\">ttn-fr-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le mois dernier, certains analystes ont revu leurs notes sur les actions de Novo Nordisk. 13 analystes ont r\u00e9v\u00e9l\u00e9 leur \u00e9valuation des actions Novo Nordisk. 8 experts classent l&#8217;action Novo Nordisk comme un achat, 3 experts recommandent de conserver l&#8217;action, 2 experts \u00e9valuent l&#8217;action comme une vente. En moyenne, les analystes pr\u00e9voient un objectif de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1133124,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[1063,17077,9504,65,145338,145337],"class_list":["post-1133123","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-action","tag-analystes","tag-attendent","tag-les","tag-nordisk","tag-novo"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/1133123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/comments?post=1133123"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/1133123\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media\/1133124"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media?parent=1133123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/categories?post=1133123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/tags?post=1133123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}